The incidence and prognostic value of HER2 overexpression and cyclin D1 expression in patients with gastric or gastroesophageal junction adenocarcinoma in Israel

Human epidermal growth factor 2 (HER2) positivity rates for gastric or gastroesophageal junction (GEJ) adenocarcinoma have been reported at 15–25%. Cyclin D1 (BCL1) is a non-specific proliferative marker. The prognostic significance of HER2 and cyclin D1 is inconclusive, with contradictory data. The...

Descripción completa

Detalles Bibliográficos
Autores principales: BAR-SELA, GIL, HERSHKOVITZ, DOV, HAIM, NISSIM, KAIDAR-PERSON, ORIT, SHULMAN, KATERINA, BEN-IZHAK, OFER
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573138/
https://www.ncbi.nlm.nih.gov/pubmed/23420289
http://dx.doi.org/10.3892/ol.2012.1031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573138/
https://www.ncbi.nlm.nih.gov/pubmed/23420289
http://dx.doi.org/10.3892/ol.2012.1031

Ejemplares similares